HIKAL Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > hikal

Technical Analysis

Technical Strength: 7.7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 62.8. According to RSI analysis, hikal is strong. 7.0 HIKAL RSI Chart
MACD (?) MACD: 4.23 and Signal Line: 2.8. According to MACD analysis, hikal is technically strong. 8.0 HIKAL MACD Chart
Simple Moving Average (?) According to simple moving average analysis, hikal is in a strong uptrend. Major support levels are 220.1225, 218.841, 184.8925. 10.0 HIKAL Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, hikal is in a strong uptrend. Major support levels are 223.8437, 218.5878, 191.4727. 10.0 HIKAL Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.925. According to bollinger bands, hikal is technically strong. 7.0 HIKAL Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 235.981 and 229.55. Resistance level is 256.8. 6.5 HIKAL Fibonacci Retracement Chart
Average True Range (?) ATR: 9.91 NA HIKAL Average True Range Chart
Average Directional Index (?) ADX is 29.6 which means HIKAL is in a trend. NA HIKAL Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 18, 2017
Open Price 226.15
High Price 238.7
Low Price 226.15
Close Price 237.0
Absolute Change 10.9
Percentage Change 4.82%
Weekly Change 1.07%
Monthly Change 10.4%
Yearly Change 53.1%
52-week high 256.8
52-week low 116.1
Corporate Actions
ExDate Purpose
August 02, 2016 AGM/DIV-RE 0.50 PER SHARE
May 17, 2016 INT DIV-RE 0.50 PER SHARE
February 27, 2015 FV SPLT FRM RS 10 TO RS 2
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.516
Confidence in Beta1.47%
Market Capital Rs. 1948.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 5.03
TTM Price-to-Earnings (P/E) Ratio 47.1
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 18 January 2017: Deliverable Quantity:5.5e+04 NA HIKAL Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 18 January 2017: Daily Volatility:0.556 NA HIKAL Annualized Daily Volatility (Spot Price) Chart

Announcements

January 13, 2017 HikalShareholders meetingl Limited has submitted to the Exchange a copy of the details regarding the voting results pertaining to postal ballot conducted by the Company vide postal ballot notice dated November 9, 2016 along with Scrutinizers Report.
January 10, 2017 HikalUpdatesl Limited has informed the Exchange that the Company's API and Intermediates manufacturing facility located at Jigani, Bangalore was recently inspected by the US FDA in compliance with their requirements. At the end of the successful inspection, we have been informed by the Investigator that ''zero'' 483 observations were issued. This was a routine inspection by the US FDA.
See all Announcements

Board Meetings

Date Meeting Date Purpose
October 28, 2016 November 09, 2016 to coResultsonsider, approve and to take on record the Unaudited Financial Results of the Company for the quarter ended September 30, 2016.
August 02, 2016 August 10, 2016 to coResultsonsider, approve and to take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2016.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 216.7 Rs. 221.4 Rs. 229.2 Rs. 234 Rs. 241.8 Rs. 246.5 Rs. 254.3